In fact, IDH2 is significantly lower expressed in normal tissue compared to tumor (Fig. 4c), and lower IDH2 expression is associated with better relapse-free survival in other breast cancer cohorts (Fig. 4d). The gene discussed is IDH2; the disease is breast carcinoma.